Abstract PS3-09-05: Real-world clinical characteristics and treatment patterns among UK and French patients with a recent diagnosis (2020 onwards) of early-stage, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (ER+/HER2-eBC)
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: P. Cottu, E. Sawyer, J. Frenel, J. R. Earla, K. M. Hirshfield, G. Gooud, D. Ntais, A. Jamotte, C. Perkins, A. Babonneau, E. Kitetere, M. Vallet, M. Riaz, J. Timbres, L. Haroun, L. Cirneanu, R. Hermans, V. Saglimbene, K. Dushkin, A. Ajmal, S. Oikonomou, A. Vladimirova, K. Desai, F. Bocquet, P. S. Hall
Institutions: Université Paris Cité, Institut Curie, King's College London, Institut de Cancérologie de l'Ouest, Merck & Co., Inc., Rahway, NJ, USA (United States), MSD (Switzerland), MSD (France), Cancer Research UK, Edinburgh Cancer Research, Institute of Genetics and Cancer, University of Edinburgh, Leeds Teaching Hospitals NHS Trust, IQVIA (United Kingdom)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129736012
Cites:
Cited by:
Related to: